Do Serum Galectin-9 Levels in Women with Gestational Diabetes and Healthy Ones Differ before or after Delivery? A Pilot Study
Authors:
- Aleksandra PełechAPAleksandra Pełech
- Monika RuszałaMRMonika Ruszała
- Magdalena Niebrzydowska-TatusMNMagdalena Niebrzydowska-Tatus
- Katarzyna BieńKBKatarzyna Bień
- Żaneta Kimber-TrojnarŻaneta Kimber-Trojnar
- Monika CzubaMCMonika Czuba
- Małgorzata ŚwistowskaMŚMałgorzata Świstowska
- Bożena Leszczyńska-GorzelakBLBożena Leszczyńska-Gorzelak
Open Access
- 20 April 2023
- journal article
- research article
- Published by MDPI AG in Biomolecules
- Vol. 13 (4) , 697
Abstract
Gestational diabetes mellitus (GDM) is a common metabolic disease that occurs during pregnancy, with the placenta playing an important role in its pathophysiology. Currently, the role of galectin-9 in the development of GDM is unknown. The aim of this study was to compare galectin-9 concentrations in healthy pregnant women and those with GDM. Galectin-9 levels were assessed in serum samples taken both just before and after delivery, as well as in urine samples collected in the postpartum period. Maternal body composition and hydration status were evaluated using the bioelectrical impedance analysis (BIA) method. There were no statistically significant differences in the concentration of galectin-9 in women with GDM compared to healthy pregnant women in their serum samples taken just before delivery, nor in their serum and urine samples collected in the early postpartum period. However, serum galectin-9 concentrations taken before delivery were positively correlated with BMI and parameters related to the amount of adipose tissue assessed in the early postpartum period. Additionally, there was a correlation between serum galectin-9 concentrations taken before and after delivery. Galectin-9 is unlikely to become a diagnostic marker for GDM. However, this subject requires further clinical research in larger groups.Keywords
Funding Information
- Medical University of Lublin (332)
This publication has 40 references indexed in Scilit:
- Immune checkpoint molecules soluble program death ligand 1 and galectin‐9 are increased in pregnancyAmerican Journal of Reproductive Immunology, 2017
- Galectin-9: From cell biology to complex disease dynamicsJournal of Biosciences, 2016
- Gestational diabetes mellitus and long-term consequences for mother and offspring: a view from DenmarkDiabetologia, 2016
- Elevated systemic galectin-1 levels characterize HELLP syndromeJournal of Reproductive Immunology, 2016
- Galectin-13/PP-13 expression in term placentas of gestational diabetes mellitus pregnanciesPlacenta, 2015
- Placental pathologic changes in gestational diabetes mellitus.2015
- Getting too sweet: galectin-1 dysregulation in gestational diabetes mellitusMolecular Human Reproduction, 2014
- Expression and function of galectins in the endometrium and at the human feto-maternal interfacePlacenta, 2013
- Serum galectin-9 levels are elevated in the patients with type 2 diabetes and chronic kidney diseaseBMC Nephrology, 2013
- The role of galectins in the initiation, amplification and resolution of the inflammatory responseTissue Antigens, 2004